New PBPK Modeling & Simulation Courses for Fall 2021
The world is constantly changing, and with the advancement of technology, it is moving at an accelerated pace.
Quantifying Exposure is the Foundation of Pharmacometric Analysis
Kevin Dykstra answers questions like, "Why do we care about Drug Exposure?"
Training and Education – Learning tomorrow’s science… today.
As I think back on 20+ years of lecturing on the population modeling & simulation (M&S) approach, I am simultaneously struck by how much has changed and how much has remained the same.
Ensuring the Quality and Accuracy of Analysis-Ready Datasets
Our experience in data assembly is extensive: we’ve been building analysis-ready datasets for pharmacometric modeling and simulation for over 25 years.
June 2021 GastroPlus Newsletter
A long time ago, in a desert far, far away…
May 2021 GastroPlus Newsletter
We hope that you and yours are coming out of our Covid enforced isolation.
Evaluating the Hepatotoxicity of Compound V with QST/QSP Modeling
Is your compound causing drug-induced liver injury?
May 2021 News/Events
Did you know? We provide high-quality analysis & support services including non-compartmental PK analysis, population PK and PK/PD modeling, PBPK modeling in GastroPlus®, and statistical modeling, focusing on...
Applications of Pharmacometrics in Phase 1 Studies
Phase 1 is a drug development stage where you start the clinical evaluation of the drug.
Using DDDPlus™ to Predict in vivo API Exposure Levels
There has been an increasing desire to incorporate mechanistic models of in vitro experiments to evaluate the interplay between...
Early assessment of PK properties with the ADMET Predictor® HTPK Simulation module, a high-throughput mechanistic PBPK approach
David Miller, Vice President of Cheminformatics, expands on this PBPK approach with the HTPK module...
Utilization of PBBM/PBPK Models for Building a Safe Space and Regulatory Applications in Support of Drug Product Quality
Sandra Suarez-Sharp, VP of Regulatory Affairs presents to the GastroPlus User Group - the concept of safe space to decrease the regulatory burden...
The GastroPlus® – Additional Dosage Routes Seminar Series
This GastroPlus Seminar series focused on the Additional Dosage Route’s module which goes beyond the traditional oral and intravenous drug...
The GastroPlus® “Workshop from Home” Seminars (April 13-17)
Physiologically based pharmacokinetic modeling & simulation is increasingly used as a tool in drug product development, not only in support...
April 2021 GastroPlus Newsletter
Happy Spring. For most of the world, we are beginning to come out of our Covid enforced isolation.